Identification of MYLK3 mutations in familial dilated cardiomyopathy

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Genetic Etiology of Heart Disease

Background:

• Dilated cardiomyopathy (DCM) is a significant cause of heart failure, arrhythmias, and sudden cardiac death.
• Genetic factors are implicated in approximately 50% of DCM cases, but the genetic basis for the remaining cases remains largely unknown.
• Identifying novel genes associated with DCM is crucial for understanding disease mechanisms and developing targeted therapies.

Observation:

• Whole exome sequencing and segregation analysis in a familial DCM pedigree identified a novel read-through mutation in the myosin light chain kinase 3 (MYLK3) gene.
• Further screening revealed another MYLK3 mutation (frameshift) in a DCM patient negative for mutations in known cardiomyopathy genes.
• In vitro and immunohistochemical studies demonstrated that these MYLK3 mutations lead to reduced protein expression and impaired myosin light chain 2 phosphorylation.

Findings:

• This study is the first to report MYLK3 gene mutations as a cause of human DCM.
• The identified MYLK3 mutations result in a loss-of-function, leading to reduced protein levels and impaired cardiac function.
• Clinical phenotypes observed in patients with MYLK3 mutations align with findings in MYLK3-deficient mouse and zebrafish models, characterized by cardiac enlargement and heart failure.

Implications:

• The findings establish MYLK3 as a novel DCM-associated gene, expanding the genetic landscape of cardiomyopathies.
• This research highlights the critical role of cardiac myosin light chain kinase in maintaining normal heart function in humans.
• Understanding the MYLK3 gene's function opens avenues for improved diagnostics and potential therapeutic strategies for DCM patients with MYLK3 mutations.